Skip to main content

DNDN News

Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015

TheStreet's Adam Feuerstein lays down his predictions for the biotech industry for 2015.

Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens

Another crazy and profitable year in biotech investing was captured 140 characters at a time.

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

One biotech CEO won accolades in 2010 only to be razzed for poor performance in 2011.

Nominees for Absolute Worst Biotechnology CEOs of 2014 Are ...

The CEOs of Aegerion, Dendron, CytRx, Galena, Repros, Northwest Bio and Retrophin deserve jeers for their performances this year, but who's the worst of the bunch?

Using Re-Engineered Immune Cells to Kill Leukemia Induces Lasting Remissions

A new form of cancer immunotherapy known as CAR-T promises to radically change the way certain blood cancers are treated.

Breaking News

I Used Royal Caribbean's Starlink Internet (And Here's What I Think)

As someone who works a lot on cruise ships, I put Royal Caribbean's new internet to the test.

Bed Bath & Beyond Closes an Entire Chain as Bankruptcy Looms

The troubled retailer has taken another major step to try to stave off closure.

AMD Stock Surges After Q4 Earnings As Data Center Revenues, Outlook Impress

“2022 was a strong year for AMD as we delivered best-in-class growth and record revenue despite the weak PC environment in the second half of the year," said CEO Lisa Su

Stock Market Today: Stocks End Higher Amid Earnings Wave With Fed In Focus; IMF Boosts Global Growth Forecast

Wall Street extended the S&P 500's solid January gains Tuesday as investors sorted through a wave of corporate earnings ahead of tomorrow's crucial Fed rate decision.